Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION vs BUROSUMAB-TWZA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPROPION vs BUROSUMAB-TWZA: Safety Overview

Metric BUPROPION BUROSUMAB-TWZA
Total FAERS Reports 35,634 5,159
Deaths Reported 8,577 27
Death Rate 24.1% 0.5%
Hospitalizations 10,246 311
Average Patient Age 44.6 yrs 33.0 yrs
% Female Patients 70.7% 66.0%
FDA Approval Date Apr 12, 2017 N/A
Manufacturer NuCare Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued Prescription